What is ABEO's current stock price?

As of now, ABEO is trading at $5.15, with a daily change of +5.53%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ABEO Stock Analysis & IQ Rating | Abeona Therapeutics

ABEO

Abeona Therapeutics

$5.15

+$0.27 | +5.53%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$7.54

MKT CAP

$262.50M

52W Low

$3.93

VOL

$2.55M

P/E Ratio

4.66

AVG VOL

$2.30M

RSI

57.66

TREND

Sideways

ABEO Stock IQ

Login to see Abeona Therapeutics (ABEO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABEO Target Price

Login to display

Strengths

ABEO Rewards

Earnings are forecast to grow

ABEO Rewards

Upgraded on attractively valued

Chart

$4.81 (+7.07%)

$6.86 (-24.93%)

$5.83 (-11.66%)

$6.01 (-14.31%)

1year

6month

3month

1month

ABEO Risk Level

ABEO has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Price under $5

Medium

LOW

HIGH

ABEO Analysts Opinion

ABEO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ABEO Analysts Opinion

ABEO Analysts opinion is negative and it remained unchanged from the past 3 months

ABEO Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

73%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

100%

ABEO Street Sentiment

ABEO Street Sentiment is bullish and have positive views on the near-term outlook

ABEO Performance Sentiment

Sentiments overview associated with ABEO events and the stock performance.

73%

27%

Positive

Negative

16 out of 22
events present

6 out of 22
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$4.48

Resistance
Price

$4.17

Current Price Range

$5.54

Show methods +

Linked to ABEO

IQ

Close Price

Change

NVS

4.27

130.44

+0.15%

ABEO Latest Analysis +

ABEO: First Patient Treated with Zevaskyn® Pushed to 4Q25 Following Assay Optimization. By Business UpdateFirst Patient Treated with Zevaskyn® Pushed to 4Q25The first patient treated with Zevaskyn was pushed back to the fourth quarter of 2025 following the optimization of a release assay during the third quarter of 2025. A full batch of drug product was produced following biopsy collection from a patient in August 2025 however that the product could not be released because a rapid sterility assa

Fri Nov 14, 2025

$4.45 | -1.77%

Activity

Potential

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2025 Earnings Call Transcript. Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2025 Earnings Call Transcript November 12 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.09515 expectations were $-0.27. Operator: Good morning everyone. And welcome to the Abeona Therapeutics third quarter 2025 conference call. At this time all participants are in a listen-only mode. The floor will be opened [….]

Thu Nov 13, 2025

$4.53 | -8.30%

Earnings

Heres Why Abeona Therapeutics Popped Higher Today. Key PointsAbeona stock surged over 25% after reporting strong earnings and receiving positive updates on Zevaskyn.

Wed Nov 12, 2025

$4.93 | +18.47%

Earnings

Momentum

Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead.

Wed Nov 12, 2025

$4.93 | +18.47%

Activity

Potential

Earnings Scheduled For November 12 2025. . Hudbay Minerals (NYSE:HBM) is projected to report quarterly earnings at $0.07 per share on revenue of $411.46 million. . European Wax Center (NASDAQ:) is estimated to report quarterly earnings at $0.11 per share on revenue of $52.59 million. . Boyd Group Services (NYSE:BGSI) is projected to report quarterly earnings at $0.66 per share on revenue of $792.07 million. . Katapult Holdings (NASDAQ:KPLT) is expected to report quarterly loss at $0.21 per share

Wed Nov 12, 2025

$4.93 | +18.47%

Earnings

What to Expect from Abeona Therapeuticss Earnings. Abeona Therapeutics (NASDAQ:) is gearing up to announce its quarterly earnings on Wednesday 2025-11-12. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Abeona Therapeutics will report an Anticipation surrounds Abeona Therapeutics'.s announcement with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.New investors should unde

Tue Nov 11, 2025

$4.17 | -1.42%

Momentum

FAQ About ABEO Stock Insights

What is ABEO current stock price?

What are ABEO stock strengths?

What is ABEO Risk Level?

What is ABEO market cap and volume?

What is ABEO current Stock IQ?

Should I buy ABEO stock right now?

Is ABEO a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABEO?

What does a 'Strong Sell' rating mean for ABEO?

What factors influence ABEO's Stock IQ?

Explore our ABEO Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABEO Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABEO Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ABEO

Abeona Therapeutics

Current Price

$5.15

+$0.27 | +5.53%

52W High

$7.54

MKT CAP

$262.50M

52W Low

$3.93

VOL

$2.55M

P/E Ratio

4.66

AVG VOL

$2.30M

RSI

57.66

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ABEO Rewards

Earnings are forecast to grow

ABEO Rewards

Upgraded on attractively valued

Linked to ABEO

Symbol

IQ

Close

Change

NVS

4.27

130.44

+0.15%

ABEO Stock IQ

Login to unlock Abeona Therapeutics (ABEO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$4.81 (+7.07%)

$6.86 (-24.93%)

$5.83 (-11.66%)

$6.01 (-14.31%)

1year

6month

3month

1month

ABEO Analysts Opinion

ABEO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ABEO Analysts Opinion

ABEO Analysts opinion is negative and it remained unchanged from the past 3 months

ABEO Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

73%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

100%

ABEO Street Sentiment

ABEO Street Sentiment is bullish and have positive views on the near-term outlook

ABEO Risk Level

ABEO has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Price under $5

Medium

LOW

HIGH

ABEO Performance Sentiment

Sentiments overview associated with ABEO events and the stock performance.

73%

27%

Positive

Negative

16 out of 22
events present

6 out of 22
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$4.48

Resistance
Price

$4.17

Current Price Range

$5.54

Show methods +

ABEO Latest Analysis

ABEO: First Patient Treated with Zevaskyn® Pushed to 4Q25 Following Assay Optimization. By Business UpdateFirst Patient Treated with Zevaskyn® Pushed to 4Q25The first patient treated with Zevaskyn was pushed back to the fourth quarter of 2025 following the optimization of a release assay during the third quarter of 2025. A full batch of drug product was produced following biopsy collection from a patient in August 2025 however that the product could not be released because a rapid sterility assa

Fri Nov 14, 2025

$4.45 | -1.77%

Activity

Potential

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2025 Earnings Call Transcript. Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2025 Earnings Call Transcript November 12 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.09515 expectations were $-0.27. Operator: Good morning everyone. And welcome to the Abeona Therapeutics third quarter 2025 conference call. At this time all participants are in a listen-only mode. The floor will be opened [….]

Thu Nov 13, 2025

$4.53 | -8.30%

Earnings

Heres Why Abeona Therapeutics Popped Higher Today. Key PointsAbeona stock surged over 25% after reporting strong earnings and receiving positive updates on Zevaskyn.

Wed Nov 12, 2025

$4.93 | +18.47%

Earnings

Momentum

Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead.

Wed Nov 12, 2025

$4.93 | +18.47%

Activity

Potential

Earnings Scheduled For November 12 2025. . Hudbay Minerals (NYSE:HBM) is projected to report quarterly earnings at $0.07 per share on revenue of $411.46 million. . European Wax Center (NASDAQ:) is estimated to report quarterly earnings at $0.11 per share on revenue of $52.59 million. . Boyd Group Services (NYSE:BGSI) is projected to report quarterly earnings at $0.66 per share on revenue of $792.07 million. . Katapult Holdings (NASDAQ:KPLT) is expected to report quarterly loss at $0.21 per share

Wed Nov 12, 2025

$4.93 | +18.47%

Earnings

What to Expect from Abeona Therapeuticss Earnings. Abeona Therapeutics (NASDAQ:) is gearing up to announce its quarterly earnings on Wednesday 2025-11-12. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Abeona Therapeutics will report an Anticipation surrounds Abeona Therapeutics'.s announcement with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.New investors should unde

Tue Nov 11, 2025

$4.17 | -1.42%

Momentum

Discover ABEO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABEO. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABEO Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABEO Stock trends

ABEO Stock performance

ABEO Stock analysis

ABEO investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABEO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABEO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

ABEO Stock Analysis & IQ Rating | Abeona Therapeutics

ABEO Stock IQ

ABEO Target Price

ABEO Risk Level

ABEO Analysts Opinion

ABEO Street Sentiment

ABEO Performance Sentiment

Technical Price Levels

Explore our ABEO Stock insights

Receive our ABEO Daily Alerts

ABEO Stock IQ

ABEO Street Sentiment

ABEO Risk Level

Technical Price Levels

Discover ABEO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABEO. We're here to help you make informed investment decisions today.

Receive our ABEO Daily Alerts

ABEO Runner Alarm